Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

covid-19_india_patientconsultation_abhinav_chatterjee_2020_msf331880_3800px Photograph by Abhinav Chatterjee
Press release
Press release |
24 November 2020
COVID-19

MSF responds to emergency use authorization for REGN-CoV-2 by the US FDA

2 min
"" Photograph by Carlos Becerra
Press release
Press release |
24 November 2020
COVID-19

AstraZeneca must open books to prove ‘no-profit’ pricing commitment and make all licenses and agreements public

4 min
The 60-bed Khayelitsha Field Hospital was developed by MSF to support the nearby Khayelitsha District Hospital to cope with the pressures of peak COVID-19 transmission in the Western Cape. Photograph by Rowan Pybus
Press release
Press release |
19 November 2020
COVID-19

MSF calls on all governments to support landmark move at WTO to suspend monopolies during COVID-19

4 min
covid 19 india ppe checksandprotocols aahanadhar 2020 Photograph by Aahana Dhar
Press release
Press release |
16 November 2020
COVID-19

MSF: Moderna must transparently share information around their COVID-19 vaccine and sell it at-cost

3 min
Kam Thianlam (42) is an MDR-TB patient at MSF’s clinic in Churachandpur. He lives in Laisang, a remote place. Irene, MSF "Direct Observation Treatment Procedures" nurse, teaches MSF nurse teaches Akungmei, a newly recruited DOTs nurse how to administer the 15 tablets he needs to take everyday so that she can follow up his adherence. Photograph by Jan-Joseph Stok
Press release
Press release |
16 November 2020
Tuberculosis

Report shows new tests and drugs for world’s deadliest infectious disease, TB, remain out of reach

4 min
covid 19 yemen patientbeingmoved jacobburns 2020 Photograph by Diego Baravelli
Press release
Press release |
11 November 2020
COVID-19

MSF: Governments must demand pharma make all COVID-19 vaccine licensing deals public

MSF intervention in Rio, Praça da Cruz Vermelha Photograph by Mariana Abdalla
Press release
Press release |
03 November 2020
COVID-19

MSF welcomes Fiocruz’s step towards transparency of AstraZeneca deal

2 min
Staff checking on patients. These are usual rounds where doctors check on the progress of the patient accompanied with a counsellor to get insights into their interactions with the patient as well. Photograph by Garvit Nangia
Press release
Press release |
28 October 2020
COVID-19

MSF response to Gavi’s intent to purchase Sanofi-GSK COVID-19 vaccine candidate for the COVAX Facility

3 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury